KPRX Company Profile and Key Details

Q: Who are the executives of KPRX?

Dr. Stefan Sperl Ph.D.Executive Vice President of CMC & OperationsDr. Eric J. Daniels M.B.A., M.D.Chief Devel. OfficerMs. Melissa ToscaExecutive Vice President of Fin.Dr. MaryJane Rafii Ph.D.ConsultantDr. Brian M. Strem Ph.D.Pres, Chief Executive Officer & DirectorMs. Melissa Tosca C.P.A.Executive Vice President of Fin.Ms. Melissa Tosca CPAExecutive Vice President of Fin.

NASDAQ : KPRX

Kiora Pharmaceuticals

$2.46

-0.05-1.99%

At Close 4:00 PM

75.83

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Kiora Pharmaceuticals, Inc. (KPRX) stock declined over -1.99%, trading at $2.46 on NASDAQ, down from the previous close of $2.51. The stock opened at $2.51, fluctuating between $2.43 and $2.57 in the recent session.

Stock Snapshot

2.51

Prev. Close

10.9M

Market Cap

2.43

Day Low

-0.91

P/E Ratio

-2.71

EPS (TTM)

-1.24

Cash Flow per Share

2.51

Open

4.43M

Number of Shares

2.5692

Day High

85.32%

Free Float in %

0.79

Book Value

16.92K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 13, 2026	2.51	2.59	2.43	2.46	16.93K
Jul 10, 2026	2.53	2.56	2.50	2.51	4.03K
Jul 09, 2026	2.55	2.57	2.52	2.55	6K
Jul 08, 2026	2.51	2.59	2.51	2.55	18.48K
Jul 07, 2026	2.59	2.59	2.55	2.55	4.53K
Jul 06, 2026	2.62	2.65	2.50	2.55	19.84K
Jul 02, 2026	2.68	2.74	2.62	2.63	8.96K
Jul 01, 2026	2.66	2.73	2.66	2.66	9.11K
Jun 30, 2026	2.58	2.65	2.58	2.63	13.35K
Jun 29, 2026	2.57	2.65	2.56	2.61	16.82K
Jun 26, 2026	2.50	2.55	2.50	2.54	7.77K
Jun 25, 2026	2.58	2.60	2.52	2.55	38.89K
Jun 24, 2026	2.65	2.65	2.54	2.59	24.69K
Jun 23, 2026	2.49	2.65	2.48	2.60	25.95K
Jun 22, 2026	2.50	2.52	2.42	2.47	20.47K
Jun 18, 2026	2.63	2.71	2.53	2.53	95.45K
Jun 17, 2026	2.53	2.60	2.49	2.57	14.78K
Jun 16, 2026	2.45	2.69	2.45	2.62	46.17K
Jun 15, 2026	2.55	2.55	2.46	2.46	46.2K
Jun 12, 2026	2.59	2.59	2.54	2.55	23.78K

Contact Details

Encinitas, CA 84105

United States

https://www.kiorapharma.com 781 788 8869

About Company

Kiora Pharmaceuticals, Inc., a specialty pharmaceutical firm operating at the clinical stage, is dedicated to the creation and commercialization of treatments for various ophthalmic conditions across the United States. Its flagship therapeutic candidate, KIO-301, is a groundbreaking small molecule undergoing Phase 1 clinical trials. This innovative "photoswitch" aims to revitalize vision in individuals suffering from both inherited and age-related forms of retinal degeneration. The company's pipeline also includes KIO-101, an eye drop currently in Phase 2 trials for addressing the ocular manifestations of rheumatoid arthritis, as well as non-infectious posterior uveitis. Furthermore, Kiora is advancing KIO-201, another eye drop, which is in Phase 3 clinical trials, designed to facilitate corneal wound healing following PRK surgery. Established in 1998, the company adopted its current name in November 2021, having previously operated as Eyegate Pharmaceuticals, Inc. Kiora Pharmaceuticals maintains its corporate headquarters in Salt Lake City, Utah.

Stock Peers

ARGX

-1.37-0.16%

argenx SE$876.25 REGN

-1.43-0.22%

Regeneron Pharmaceuticals, Inc.$663.09 UTHR

-11.49-2.10%

United Therapeutics Corporation$535.57 MDGL

-5.7-1.06%

Madrigal Pharmaceuticals, Inc.$531.00 VRTX

-5.14-1.06%

Vertex Pharmaceuticals Incorporated$480.25 KRYS

-2.37-0.65%

Krystal Biotech, Inc.$363.44 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

-10.43-3.21%

Praxis Precision Medicines, Inc.$314.56 LGND

-6.99-2.21%

Ligand Pharmaceuticals Incorporated$309.25 ONC

5.26001+1.76%

BeOne Medicines AG$303.96

Frequently Asked Questions

What is the current Kiora Pharmaceuticals, Inc. (KPRX) stock price?

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) stock price is $2.46 in the last trading session. During the trading session, KPRX stock reached the peak price of $2.57 while $2.43 was the lowest point it dropped to. The percentage change in KPRX stock occurred in the recent session was -1.99% while the dollar amount for the price change in KPRX stock was - $0.05.

KPRX's industry and sector of operation?

The NASDAQ listed KPRX is part of Biotechnology industry that operates in the broader Healthcare sector. Kiora Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of KPRX?

Dr. Stefan Sperl Ph.D.
Executive Vice President of CMC & Operations
Dr. Eric J. Daniels M.B.A., M.D.
Chief Devel. Officer
Ms. Melissa Tosca
Executive Vice President of Fin.
Dr. MaryJane Rafii Ph.D.
Consultant
Dr. Brian M. Strem Ph.D.
Pres, Chief Executive Officer & Director
Ms. Melissa Tosca C.P.A.
Executive Vice President of Fin.
Ms. Melissa Tosca CPA
Executive Vice President of Fin.

How KPRX did perform over past 52-week?

KPRX's closing price is 39.38% higher than its 52-week low of $1.77 where as its distance from 52-week high of $3.29 is -25.23%.

How many employees does KPRX have?

Number of KPRX employees currently stands at 12.

Link for KPRX official website?

Official Website of KPRX is: https://www.kiorapharma.com

How do I contact KPRX?

KPRX could be contacted at phone 781 788 8869 and can also be accessed through its website. KPRX operates from 1371 East 2100 South, Encinitas, CA 84105, United States.

How many shares of KPRX are traded daily?

KPRX stock volume for the day was 16.92K shares. The average number of KPRX shares traded daily for last 3 months was 41.6K.

What is the market cap of KPRX currently?

The market value of KPRX currently stands at $10.90M with its latest stock price at $2.46 and 4.43M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	12
Beta	-0.39
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	12
Beta	-0.39
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

KPRX Company Profile and Key Details

Kiora Pharmaceuticals

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Earnings & Analyst Outlook

Dividend & Fair Value

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways